Literature DB >> 10872087

Osmotically controlled oral drug delivery.

R K Verma1, B Mishra, S Garg.   

Abstract

It is advantageous to deliver some drugs with short half-life, and which are to be given frequently for chronic ailments, in the form of controlled-release (CR) formulations. The orally administered drugs, in the form of conventional matrix or reservoir type formulations, pose problems of bioavailability fluctuations due to gastric pH variations. Moreover, the release of drug(s) from these systems is affected by the hydrodynamic conditions of the body. Osmotically controlled drug delivery systems utilize the principles of osmotic pressure for the controlled delivery of active agent(s). The release rate of drug(s) from these systems is independent of the physiological factors of the gastrointestinal (GI) tract to a large extent. In the present review, theory underlying the delivery of drugs from osmotic systems is presented. Different types of oral osmotic systems, their advantages over conventional matrix and reservoir types of systems, and their applications are also discussed. Finally, some of the limitations, adverse effects, and patent and market status of these systems are reviewed. These systems form a major segment of drug delivery products. Because of their advantages and strong market potential, it appears that the future of osmotic systems in rate-controlled oral drug delivery is promising.

Mesh:

Year:  2000        PMID: 10872087     DOI: 10.1081/ddc-100101287

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  18 in total

1.  Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.

Authors:  Siddhartha Maity; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2015-08-14       Impact factor: 3.246

2.  Floating osmotic drug delivery system of ranitidine hydrochloride: development and evaluation--a technical note.

Authors:  Pramod Kumar; Sanjay Singh; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2008-03-18       Impact factor: 3.246

3.  Controlling Release of Integral Lipid Nanoparticles Based on Osmotic Pump Technology.

Authors:  Zhiqiang Tian; Qin Yu; Yunchang Xie; Fengqian Li; Yi Lu; Xiaochun Dong; Weili Zhao; Jianping Qi; Wei Wu
Journal:  Pharm Res       Date:  2016-05-09       Impact factor: 4.200

Review 4.  Polymers for drug delivery systems.

Authors:  William B Liechty; David R Kryscio; Brandon V Slaughter; Nicholas A Peppas
Journal:  Annu Rev Chem Biomol Eng       Date:  2010       Impact factor: 11.059

5.  Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers.

Authors:  Sanju Dhawan; Bhupinder Singh; Santosh Kumar Garg; Debasish Hota; Radharaman Jiban Dash; Anil Kumar Singla; Vivek Ranjan Sinha
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

6.  Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.

Authors:  Meena Rani; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2004-08-20       Impact factor: 3.246

7.  Floating elementary osmotic pump tablet (FEOPT) for controlled delivery of diethylcarbamazine citrate: a water-soluble drug.

Authors:  Zulfequar Ahamad Khan; Rahul Tripathi; Brahmeshwar Mishra
Journal:  AAPS PharmSciTech       Date:  2011-10-04       Impact factor: 3.246

8.  Zero-order controlled release of ciprofloxacin-HCl from a reservoir-based, bioresorbable and elastomeric device.

Authors:  Irene S Tobias; Heejin Lee; George C Engelmayr; Daniel Macaya; Christopher J Bettinger; Michael J Cima
Journal:  J Control Release       Date:  2010-06-04       Impact factor: 9.776

Review 9.  The use of nanoparticulates to treat breast cancer.

Authors:  Xiaomeng Tang; Welley S Loc; Cheng Dong; Gail L Matters; Peter J Butler; Mark Kester; Craig Meyers; Yixing Jiang; James H Adair
Journal:  Nanomedicine (Lond)       Date:  2017-09-04       Impact factor: 5.307

10.  Osmotically regulated floating asymmetric membrane capsule for controlled site-specific delivery of ranitidine hydrochloride: optimization by central composite design.

Authors:  Manvendra S Chauhan; Anil Kumar; Kamla Pathak
Journal:  AAPS PharmSciTech       Date:  2012-10-27       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.